Perry Cohen, Pharm.D., a longtime member of the Managed Healthcare Executive editorial advisory board, is host of the ...

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...

"All kinds of enhancements" have crept into claims from providers, Ronanki said, and health plans have responded. But his ...

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...

In an interview, James D. Chambers, Ph.D., from Tufts Medical Center, talks about the factors that are impacting the ...

Ibtrozi had a 90% response rate in treatment naïve adults with locally advanced or metastatic ROS1-positive non-small cell ...

According to a new study in Haemophilia, up to 60% of patients with severe HA have no known family history, making early ...

These tools, available through the myCigna member portal, are designed to make navigating health insurance more ...

EGFR inhibitors such as Erbitux and Gilotrif show potential in laboratory and mouse studies in treating melanoma with a ...

Although some HIV programs will remain, the proposed cuts in the fiscal year 2026 budget are too severe and will hinder HIV ...

The Arthritis Foundation is funding a study to help predict the onset and progression of interstitial lung disease in ...